Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Schwäbisch Hall – page 2

19 clinical trials in Schwäbisch Hall, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Schwäbisch Hall at a glance
19
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

19 trials in Schwäbisch Hall

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Codeine Phosphate
  • Sponsor:Merck Sharp & Dohme LLC
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Universitaetsklinikum Heidelberg AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Universitaetsklinikum Ulm AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bleomycin Sulfate
  • Sponsor:University Of Cologne
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Universitaetsklinikum Heidelberg AöR

Cardiac failure

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azilsartan Medoxomil
  • Sponsor:Novartis Pharma AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:AstraZeneca AB

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Schwäbisch Hall

What the registry says about research in the country

01 Hematologic Oncology

Innovative research focusing on chronic lymphocytic leukemia and multiple myeloma, evaluating novel therapeutic approaches and maintenance strategies post stem-cell transplantation.

  • Treatment-naive and relapsed leukemia studies
  • Post-transplantation maintenance therapy
  • Novel drug combinations assessment

These trials aim to improve patient outcomes through targeted therapies and innovative treatment combinations.

02 Lymphoma Research

Advanced studies in Hodgkin Lymphoma and follicular lymphoma, investigating reduced toxicity treatments and combination therapies.

  • Treatment optimization studies
  • Toxicity reduction protocols
  • Novel therapeutic combinations

Research focuses on developing more effective and better-tolerated treatment regimens.

03 Solid Tumor Studies

Comprehensive research in metastatic colorectal cancer and endometrial cancer, examining post-surgical treatment strategies and molecular-based approaches.

  • Post-resection therapy optimization
  • Molecular-based treatment selection
  • Surgical outcome improvement

These trials aim to enhance treatment efficacy and patient survival through personalized approaches.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.